WEST LAFAYETTE, IN, April 11, 2022 — Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), s pleased to announce that Fernanda Beraldi has joined the Company as General Counsel and Corporate Secretary as we continue to invest in building an industry-leading executive management team to support our evolving business.

Beraldi joins Inotiv with a storied career in multinational corporate and commercial law and a passion for helping people. Her key responsibilities will include:

Fernanda Beraldi, General Counsel and Corporate Secretary

Beraldi joins Inotiv with a storied career in multinational corporate and commercial law and a passion for helping people. Her key responsibilities will include:

• 🔸Preparing, reviewing and negotiating company contracts, requests for proposals and other legal documents, including vendor agreements, real estate leases and construction contracts
• 🔸Consulting with management, commercial advisors, tax experts, accountants and marketing staff
• 🔸Advising on employment matters
• 🔸Developing Inotiv’s policies on industry-specific issues, corporate governance and regulatory affairs
• 🔸Reviewing, addressing and guiding all company-related legal risks
• 🔸Ensuring that the Board has the resources to fulfill its fiduciary duties to the company’s shareholders

“Fernanda joining our Inotiv community as an executive leader is another contemporary footstep in Inotiv’s history,” said President and CEO, Robert Leasure, Jr. “I know Fernanda is eager to immediately engage with our leadership in planning and decision making and we are confident her talent and experience will further strengthen our world-class team.”

“I love Inotiv’s commitment to supporting discovery and development objectives as well as helping researchers realize the full potential of their critical R&D projects,” said Beraldi. “Inotiv’s purpose of helping to build a healthier and safer world is very much in line with my professional and personal purposes.”

Beraldi earned her Bachelor of Laws and her Master of Laws degrees in Corporate Law from Sao Paulo, Brazil’s Mackenzie University. She also holds a Master of Laws in Corporate and Commercial Law from Indiana University’s Robert H. McKinney School of Law, cum laude. Beraldi was recognized as 2019’s Top 10 “30-somethings” from the Association of Corporate Counsel (ACC), and 2020’s “Forty Under 40” from the Indianapolis Business Journal. She is also the co-founder and current President of Business Ethics Indiana, a group of Ethics & Compliance senior leaders in Indiana with a mission to “promote ethical business practices and provide professional development that strengthens Indiana as a business ethics center of excellence.”

About Inotiv
Inotiv, Inc. is a leading contract research organization dedicated to providing nonclinical and analytical drug discovery and development services and research models and related products and services. The Company’s products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development, all while increasing efficiency, improving data, and reducing the cost of taking new drugs to market. Inotiv is committed to supporting discovery and development objectives as well as helping researchers realize the full potential of their critical R&D projects, all while working together to build a healthier and safer world. Further information about Inotiv can be found here: https://www.inotivco.com/.

This release may contain forward-looking statements that are subject to risks and uncertainties including, but not limited to, risks and uncertainties related to changes in the market and demand for our products and services, the development, marketing and sales of products and services, changes in technology, industry and regulatory standards, the timing of acquisitions and the successful closing, integration and business and financial impact thereof, governmental regulations, inspections and investigations, the impact of site closures and consolidations, expansion and related efforts, and various other market and operating risks, including those detailed in the Company's filings with the U.S. Securities and Exchange Commission.